Bristol-Myers Squibb Co at Goldman Sachs Healthcare C-Suite Unscripted Conference Transcript
Welcome to 2024. Anyway, my name is Chris Shibutani. I'm a member of the Goldman Sachs health care team. We are deeply grateful for the teams that were able to join us for this conference this very early date this year, and obviously, the point is to try and give voice and an opportunity to talk about some of the most interesting and intriguing stories across the health care landscape ahead of next week's confab. I am especially pleased to once again be able to be joined on stage by Adam Lenkowsky who recently got a promotion to Chief Commercialization Officer from your role previously. So Adam, thank you very much for joining us.
Thank you, Chris. Happy New Year.
Yes, indeed. And especially appreciative to the IR team as well, Tim Power
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
